Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MEDICAL PPTYS   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Straight-line rent158.88110.4674.7465.4741.0723.3813.5110.717.915.28
Rent billed741.31474.15473.34435.78327.27247.60187.02132.58119.88105.69
Income from direct financing leases206.55119.6273.9874.5064.3158.7249.1640.8321.73--
Interest and fee income142.50149.97162.46129.00108.49112.1862.8558.4148.6021.36
Total Revenues1,249.24854.20784.52704.75541.14441.88312.53242.52198.13132.32
Property-related24.8923.999.245.812.713.791.852.451.480.72
Real estate depreciation and amortization264.25152.31133.08125.1194.3769.8753.9436.9832.8230.15
General and administrative131.6696.4181.0058.6048.9143.6437.2730.0628.5627.09
Costs of terminated acquisitions--------------------
Acquisition expenses------29.6546.2761.3426.3919.495.424.18
Impairment charge------0.00(7.23)0.00(50.13)0.00----
Interest(328.73)(237.83)(223.27)(176.95)(159.60)----------
Total operating expenses749.53510.55446.60396.12351.87178.64169.5888.9968.2762.15
Operating Income (Loss)----------263.24142.95153.54129.8570.18
Interest expense----------120.8898.1666.7558.2443.81
Real estate impairment charges19.0121.0348.01--------------
Gain on sale of real estate and other asset dispositions, net(2.83)41.56719.397.4361.223.272.86------
Earnings from equity and other interests20.4216.0514.1710.06--2.852.563.552.940.08
Interest income--------------(0.32)(1.66)0.02
Other income (expense)(6.78)(0.35)(4.07)0.37(1.62)(2.67)2.62------
Debt refinancing costs(28.18)(6.11)0.00(32.57)(22.54)(4.37)(1.70)0.00--(14.21)
Net Non Operating Expenses(36.38)30.13681.48(14.71)29.84(123.31)(92.15)(64.24)(56.98)--
Pre-Tax Income463.33373.781,019.40293.92219.11141.43--90.03----
Income tax expense (benefit)31.06(2.62)0.932.68(6.83)1.500.340.730.020.13
Current - Domestic(0.06)(0.06)(0.13)(0.04)0.04----------
Current - Foreign10.201.673.293.061.86----------
Deferred - Domestic10.68(5.49)(3.71)(0.23)0.15----------
Deferred - Foreign10.241.261.47(0.11)(8.88)----------
Income from continuing operations----------139.9350.8089.3072.8712.12
Income from discontinued operations----------0.000.007.9117.2114.59
Consolidated net income (loss)432.27376.401,018.48291.24225.94139.9350.8097.2290.0826.71
Net income attributable to non-controlling interests0.821.721.791.450.890.330.270.220.180.18
Net income (loss) available to common shareholders431.45374.681,016.69289.79225.05139.6050.5296.9989.9026.54
Income from continuing operations----------0.640.290.590.540.10
Income from discontinued operations--------------0.050.130.13
Net Earnings Per Share (Basic)0.810.872.770.820.860.640.290.640.670.23
Income from continuing operations----------0.630.290.580.540.10
Income from discontinued operations--------------0.050.130.13
Net Earnings Per Share (Diluted)0.810.872.760.820.860.630.290.630.670.23
Weighted Average Shares Outstanding (Basic)529.24427.08365.36349.90260.41218.00170.00151.44132.33110.62
Weighted Average Shares Outstanding (Diluted)530.46428.30366.27350.44261.07218.30170.54152.60132.33110.63
Funds From Operations (FFO)757.68535.77485.34408.51253.48205.17106.68126.29107.5055.29